NA
GWPH

Neuburgh Advisers’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Neuburgh Advisers’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$618K Hold
5,372
– – 0.02% 414
2019
Q2 		$926K Sell
5,372
-102
-2% -$17.6K 0.03% 327
2019
Q1 		$923K Buy
5,474
+3,842
+235% +$572K 0.03% 313
2018
Q4 		$159K Buy
+1,632
New +$214K 0.01% 689

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Neuburgh Advisers's GWPH Position: Q3 2019 in Review

Neuburgh Advisers held its GW Pharmaceuticals Plc American Depositary Shares (GWPH) position steady in Q3 2019 at 5,372 shares worth $618K. The position accounts for 0.02% of the portfolio, ranked #414.

Neuburgh Advisers first reported a position in GWPH in Q4 2018 and has held it in 4 quarters since. The position peaked at $926K in Q2 2019. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

  • Neuburgh Advisers held 5,372 shares of GW Pharmaceuticals Plc American Depositary Shares worth $618K as of Q3 2019.
  • Neuburgh Advisers left its GW Pharmaceuticals Plc American Depositary Shares share count unchanged in Q3 2019.
  • GW Pharmaceuticals Plc American Depositary Shares made up 0.02% of Neuburgh Advisers's portfolio in Q3 2019, its #414 holding.
  • Neuburgh Advisers first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and has held it in 4 quarters since.
  • Neuburgh Advisers's GW Pharmaceuticals Plc American Depositary Shares position peaked at $926K in Q2 2019.
  • 316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.